Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor

CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells

(2018) K. Oleinika et al.   Nature Communications

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression

(2018) Filippo Cortesi et al.   Cell Reports

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy

(2018) Benjamin J. Wolf et al.   Frontiers in Immunology

Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice

(2017) Naveena B. Janakiram et al.   IMMUNOLOGY

Type II NKT Cells and Their Emerging Role in Health and Disease

(2017) Madhav V. Dhodapkar et al.   JOURNAL OF IMMUNOLOGY

Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer

(2017) Simon Gebremeskel et al.   Cancer Immunology Research

Natural Killer T Cells in Cancer Immunotherapy

(2017) Shiny Nair et al.   Frontiers in Immunology

Natural Killer T Cell-Targeted Immunotherapy Mediating Long-term Memory Responses and Strong Antitumor Activity

(2017) Nyambayar Dashtsoodol et al.   Frontiers in Immunology

Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses

(2017) Lianjun Zhang et al.   Frontiers in Immunology

The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy

(2017) Sourav Paul et al.   Frontiers in Immunology

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses

(2017) Reem Ghinnagow et al.   OncoImmunology

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo

(2016) Gengwen Tian et al.   JOURNAL OF CLINICAL INVESTIGATION

Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells

(2016) Sourav Paul et al.   OncoImmunology

Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response

(2015) You Jeong Lee et al.   IMMUNITY

IFN- -Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses

(2014) M. Moreno et al.   JOURNAL OF IMMUNOLOGY

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors

(2012) Karsten A. Pilones et al.   Clinical & Developmental Immunology

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity

(2012) Daofeng Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Development and Function of Invariant Natural Killer T Cells Producing TH2- and TH17-Cytokines

(2012) Hiroshi Watarai et al.   PLOS BIOLOGY

Trial watch

(2012) Laura Senovilla et al.   OncoImmunology

IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells

(2011) L. E. Gordy et al.   JOURNAL OF IMMUNOLOGY

Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a  -linked self-glycolipid

(2010) P. Arrenberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

(2010) F. Bellora et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

(2009) Liping Song et al.   JOURNAL OF CLINICAL INVESTIGATION

PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells

(2009) V. V. Parekh et al.   JOURNAL OF IMMUNOLOGY

Enrichment of Human CD4+ V 24/V 11 Invariant NKT Cells in Intrahepatic Malignant Tumors

(2009) G. Bricard et al.   JOURNAL OF IMMUNOLOGY

Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1

(2009) S. Kojo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases

(2008) Johan W. Molling et al.   IMMUNOLOGY LETTERS

Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population

(2008) J. M. Coquet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA